[1] |
李楠,吴露露,裴育,等.肿瘤源性骨软化症的临床特征[J].中华骨质疏松和骨矿盐疾病杂志, 2020, 13(1): 1-7.
|
[2] |
Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets[J]. Cancer, 1987, 59(8): 1442-1454.
|
[3] |
Tenenhouse HS, Sabbagh Y. Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders[J]. Pflugers Arch, 2002, 444(3): 317-26.
|
[4] |
Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol, 2004, 28(1): 1-30.
|
[5] |
David K, Revesz T, Kratimenos G, et al. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report[J]. J Neurosurg, 1996, 84(2): 288-292.
|
[6] |
Abramson M, Glezerman IG, Srinivasan M, et al. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer[J]. Clin Nephrol, 2021, 95(2): 104-111.
|
[7] |
Gökyer A, Sayın S, Küçükarda A, et al. Nasal hemangiopericytoma presenting with oncogenic osteomalasia: a case report and literature review[J]. Curr Probl Cancer, 2021, 45(3): 100704.
|
[8] |
Minisola S, Peacock M, Fukumoto S, et al. Tumour-induced osteomalacia[J]. Nat Rev Dis Primers, 2017, 3: 17044.
|
[9] |
Wilkins GE, Granleese S, Hegele RG, et al. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor[J]. J Clin Endocrinol Metab, 1995, 80(5): 1628-1634.
|
[10] |
Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis[J]. Bone, 27(3): 333-338.
|
[11] |
李媛,李致远,钟定荣.中枢神经系统原发性磷酸盐尿性间叶性肿瘤[J].诊断病理学杂志, 2018, 25(6): 401-405.
|
[12] |
Winters R, Bihlmeyer S, McCahill L, et al. Phosphaturic mesenchymal tumour-mixed connective tissue variant without oncogenic osteomalacia[J]. J Clin Pathol, 2009, 62(8): 760-761.
|
[13] |
张姝,王玲,王瞳,等. 68Ga-DOTA-TATE正电子发射断层显像/计算机断层显像对99mTc-HYNIC-TOC单光子发射断层显像阴性瘤源性骨软化症致病肿瘤的定位价值[J].中国医学科学院学报, 2018, 40(6): 757-764.
|
[14] |
Ogura E, Kageyama K, Fukumoto S, et al. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23[J]. Intern Med, 2008, 47(7): 637-641.
|
[15] |
Bahrami A, Weiss SW, Montgomery E, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia[J]. Am J Surg Pathol, 2009, 33(9): 1348-1354.
|
[16] |
Lee JC, Su SY, Changou CA, et al. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors[J]. Mod Pathol, 2016, 29(11): 1335-1346.
|
[17] |
Reis-Filho JS, Paiva ME, Lopes JM. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia[J]. Brain Pathol, 2004, 14(1): 111-112, 115.
|
[18] |
Uno T, Kawai K, Kunii N, et al. Osteomalacia caused by skull base tumors: report of 2 cases[J]. Neurosurgery, 2011, 69(1): E239-E244; discussion E244.
|